Piramal Pharma Ltd, a subsidiary of billionaire Ajay Piramal-promoted Piramal Enterprises Ltd (PEL), said it has completed the sale of a 20% stake to US-based private equity giant The Carlyle Group for ₹3,523.40 crore.
Loading - Please wait
Date posted: Thursday 8 October 2020
Piramal Pharma Ltd, a subsidiary of billionaire Ajay Piramal-promoted Piramal Enterprises Ltd (PEL), said it has completed the sale of a 20% stake to US-based private equity giant The Carlyle Group for ₹3,523.40 crore.